Your Market Research Library
 

Ask For A FREE Membership Here !
 


Your Market Research starts at Allbizreport !
Order here all your market reports, company profiles, country analysis, competitive intelligence ... upon any industries and countries :
20.000 market research, 5.000 company profiles, 150 industry monitor

   
  
   
   
   Advanced Search     

   
  
   
  
   
   


Home

The CRO Market Outlook: Emerging markets, leading players and future trends
Market Report, May 2007, 2300  €


Description

The CRO Market OutlookOver the last decade rising pressure to reduce costs and time-to-market has lead to a rapid expansion of the global Contract Research Organization (CRO) market.
Pharmaceutical and biotechnology company spend on CRO services has shown double digit growth in the past years highlighting the importance of this fast growing market.The CRO Market Outlook assesses the drivers and restraints of the global CRO market, highlighting key trends and identifying offshore outsourcing opportunities in fast-growing emerging markets such as China, India and Latin America.
This report also profiles the major international CRO players providing market share data and detailed analysis on current and future R&D spend.Use this report to improve your understanding of the evolving CRO business models and ensure that you are able to implement the optimal outsourcing strategy for your company’s needs.Key findings of the report...
• The total CRO market size is estimated at $14bn in 2006 and expected to grow at an annual rate of 14-16% to reach $24bn through 2010.
The market is highly fragmented and the number of CROs worldwide has reached over 1,100 despite continued consolidation.
• CROs provide substantial global capacity to drug developers and have become critical contributors to clinical trial activity.
Clinical trials conducted by CROs are completed up to 30% more quickly than those conducted in-house by pharma companies.
• Of the large, global contract research providers, Quintiles is market leader, with 14% of the global market share, followed by Covance and PPD, holding 10% each.
The five largest CROs have increased their market share and now hold 45% of the total market.
• The leading CROs are commodity full service providers operating on a global scale.
They act as one-stop shops for all services, from preclinical through marketing.
• CROs and pharmaceutical companies are turning to strategic partnerships to gain a competitive edge in the global business environment.Key questions answered in this report
• What will the size and growth of the global CRO market be through 2010?
• Which companies are current and future key players in the CRO market?
• What kind of business relationships will pharma companies and CRO establish in the future?
• Which business model approach will CROs adopt?
• Where will future CROs be based?
• What is limiting contract research in traditional markets?
• What impact will Electronic Data Capture have on the clinical trials industry?
• How will biomarkers influence the R&D work of CROs?Top five reasons to order your copy today
• Examine key trends which are currently affecting the market such as globalization, consolidation, Electronic Data Capture, strategic partnerships with clients and the future use of biomarkers in clinical research.
• Analyze of the most important challenges affecting the clinical research industry such as growing competition, the shortage of clinical research personnel and patient recruitment.
• Gain access to company analysis and market share for each of the major international players, including Quintiles, Covance, PPD, Charles River Laboratories and PAREXEL.
• Evaluate outsourcing trends including new technologies, novel contract alliances within the industry and emerging CRO markets.
• Understand the evolving CRO business models and ensure that you are able to implement the optimal outsourcing strategy for your company’s needs.

Sommaire
 
Table of Contents
The CRO Market Outlook
Executive Summary 12
The global contract research organization market 12
CRO market analysis 13
Regional analysis of the CRO market 14
Leading players in the global CRO market 15
The future of contract research 16
Chapter 1 The global contract research
organization market 18
Summary 18
Introduction 19
The CRO contribution to drug development 19
Market overview 20
Key market drivers 21
Key market restraints 21
Conclusions and key findings 22
Overview of the global CRO market 23
Total revenue forecasts 23
Global R&D expenditure and CRO market size 24
Global clinical development outsourcing 25
The contribution of CRO to drug development 27
Current market drivers 30
Growth of R&D expenditure from biotech and pharma 30
Cost pressures encourage R&D outsourcing 32
Strong growth and R&D expenditure of biotechnology companies 34
Growing regulatory burden and safety concerns 36
US 36
EU 36
Patient recruitment 37
Strong demand for early development services 37
The development of biomarkers 38
Current market restraints 39
Growing competition and customer consolidation 39
New financial realities alter biopharmaceutical outsourcing landscape 40
Shortage of clinical research personnel 41
Electronic data capture: a threat to CRO revenue 42
Key market trends 44
Globalization 44
EDC evolution 44
Strategic partnerships 45
Chapter 2 CRO market analysis 48
Summary 48
Introduction 49
Competitive analysis 50
Market share analysis 50
Competitive dynamics 52
Academic Medical Centers 52
Site management organizations 54
Laboratory analytical services 55
Non-CRO niche service providers 56
Conclusions 56
CRO service models 57
Introduction 57
The full service model 58
SWOT analysis 60
The niche model 61
SWOT analysis 63
Industry strategies 64
Consolidation: Mergers & acquisitions in the CRO industry 64
Expanding the continuum of services: vertical integration 66
Forward integration 66
Backward integration 67
Industry challenges 68
Consolidation within the CRO industry: a threat to close customer
relationships 68
Strategic outsourcing: demonstrating clear value to clients 69
Co-Development: sharing the risk 70
Chapter 3 Regional analysis of the CRO
market 74
Summary 74
Introduction 75
The US CRO Market 77
Overview 77
Drivers of the US CRO Market 78
Strong R&D development 78
Robust biotech funding 79
Increasing cost pressure 79
Aging population 79
Increased regulatory environment 80
Challenges of the US CRO Market 80
Patient recruitment 80
Local clinical trial costs 81
Competitive dynamics 82
The CRO Market in Western Europe 84
Overview 84
Infrastructure and local regulations 86
Drivers of the CRO market in Western Europe 87
Challenges of the CRO Market in Western Europe 88
Competitive dynamics 89
The Central and Eastern European CRO market 91
Overview 91
Infrastructure and local regulations 92
The benefits of the CEE CRO market 94
Challenges of the CEE CRO market 95
Competitive dynamics 96
The CRO market in China 98
Overview 98
Infrastructure and local regulations 99
The benefits of outsourcing to China 100
The challenges of outsourcing to China 101
Competitive dynamics 103
The CRO market in India 106
Overview 106
Infrastructure and local regulations 107
Intellectual property 108
Legislative reforms 108
The benefits of outsourcing to India 109
The challenges of outsourcing to India 109
Competitive dynamics 111
The CRO market in Latin America 113
Overview 113
Infrastructure and local regulations 115
Argentina 115
Brazil 116
Mexico 116
The benefits of outsourcing to Latin America 116
The challenges of outsourcing to Latin America 118
Competitive dynamics 119
Chapter 4 Leading players in the global
CRO market 123
Summary 123
Introduction 124
The client perspective 125
Capabilities of leading CROs 126
Quintiles Transnational Corp 128
Company profile 128
Business description 128
Global operations and recent deals 129
Covance 130
Company profile 130
Business description 130
Partnering collaborations and recent deals 131
PPD Inc. 132
Company profile 132
Business description 132
Partnering collaborations and recent deals 133
Charles River Laboratories 134
Company Profile 134
Business description 134
Partnering collaborations and recent deals 135
PAREXEL International 136
Company profile 136
Business description 136
Partnering collaborations and recent deals 137
MDS Inc 138
Company profile 138
Business description 138
Partnering collaborations and recent deals 140
ICON plc. 141
Company profile 141
Business description 141
Partnering collaborations and recent deals 142
PharmaNet Development Group 143
Company profile 143
Business description 143
Partnering collaborations and recent deals 144
Kendle International 145
Company profile 145
Business description 145
Partnering collaborations and recent deals 146
Omnicare Clinical Research 147
Company profile 147
Business description 147
Partnering collaborations and recent deals 148
Chapter 5 The future of contract research 151
Summary 151
Introduction 152
The shift towards a strategic model 152
Emerging markets and the future of CROs 155
Emerging markets 156
India 156
China 157
Central and Eastern Europe 157
Latin America 158
Africa 158
Conclusions 158
Electronic Data Capture and the future eCRO 159
Biomarkers 162
Conclusion 165
Key findings and conclusions 166
Chapter 6 Appendix 169
Bibliography 169
Index 171
List of Figures
Figure 1.1: Estimated CRO total market revenues, 2000-2010e 23
Figure 1.2: Global development expenditure and CRO market forecast, 2004-2010e 24
Figure 1.3: Global expenditure on clinical development and CRO market forecast 2004-2010e 26
Figure 1.4: Days actual submission exceeded projected submission date 28
Figure 1.5: Clinical research personnel, ACRO Members, 2002-2008e 29
Figure 1.6: Global pharmaceutical R&D expenditure, 2000-2008e 31
Figure 1.7: Comparison of drug development cost estimates 32
Figure 1.8: Global biotech R&D expenditure, 2004-2010e 35
Figure 1.9: Total EDC Provider Revenue and Revenue Loss by CROs 43
Figure 2.10: Market share of major players, 2006 50
Figure 2.11: Top five CROs market share trends, 2001-2007e 51
Figure 2.12: Typical full service CRO model 59
Figure 3.13: Geographic distribution of clinical trials, 1998 and 2008 76
Figure 3.14: R&D expenditures of PhRMA members and non-member companies, 1980-2006 78
Figure 3.15: US Clinical trials by therapeutic category, 2005 80
Figure 3.16: Overall indexed clinical trial costs, 2006 81
Figure 3.17: US CROs market share, 2005 83
Figure 3.18: The European CRO market – revenue forecast 2004-2010e 84
Figure 3.19: Pharmaceutical R&D expenditure in Europe, 1990-2005 85
Figure 3.20: Percentage of outsourced R&D work by type of organization, 2005 89
Figure 3.21: European CRO market – market share by company, 2005 90
Figure 3.22: Clinical trial costs of European countries compared to UK 91
Figure 3.23: Comparison of registration periods in CEE countries 93
Figure 3.24: Revenue forecasts, China 2006-2011e 99
Figure 3.25: China’s capabilities across the value chain 103
Figure 3.26: Revenue forecasts, India 2006-2011 107
Figure 3.27: Clinical trials by Latin American country, 2006 114
Figure 3.28: Distribution of the Latin American pharmaceutical market, 2005 115
Figure 4.29: Revenue growth of top CROs in 2006 124
Figure 4.30: Capabilities of leading CROs, 2007 127
Figure 4.31: MDS business units 2005 vs. 2008 139
Figure 4.32: Comparison of ICON sales growth vs. main competitors 142
Figure 5.33: Attractiveness of geographic regions for patient recruitment 156
Figure 5.34: Electronic data capture market size, 2001-2007 162
List of Tables
Table 1.1: Types of relationships between CROs and pharma companies 46
Table 2.2: The global R&D outsourcing market: five major segments 52
Table 2.3: SWOT analysis: the full service model 60
Table 2.4: SWOT analysis: the niche model 63
Table 3.5: Domestic CROs 105
Table 3.6: Major multinational CROs in China 106
Table 3.7: India’s capabilities across the value chain 111
Table 3.8: Major CROs (global & domestic) operating in Latin America, 2006 119
Table 4.9: Revenues ($m) and growth of major CROs, 2005-6 125
Table 5.10: EDC Promoters 161

[ Home ] [ Contact ] [ Site Map ]
© UBIQUICK SARL tous droits réservés